Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Herbalife ( (HLF) ) has shared an update.
At its 2026 Annual General Meeting on April 30, 2026, Herbalife shareholders elected eleven directors, approved on an advisory basis the compensation of named executive officers, and ratified the appointment of PricewaterhouseCoopers as independent auditor for fiscal 2026. These votes reaffirm the company’s existing governance structure and executive pay framework, supporting continuity in oversight as Herbalife pursues its current strategic and financial plans.
For the first quarter ended March 31, 2026, Herbalife reported net sales of $1.3 billion, up 7.8% year over year and above guidance, with adjusted EBITDA of $175.7 million and net income of $61.9 million, while reducing its total leverage ratio to 2.7 times. The company completed a $1.45 billion senior secured debt refinancing expected to generate material annual interest savings, acquired Bioniq’s core personalized nutrition business for up to $150 million in total potential consideration, and raised full-year 2026 constant-currency net sales and adjusted EBITDA guidance midpoints, signaling strengthening financial flexibility and a deeper push into personalized nutrition.
Herbalife is rolling out a global packaging redesign to emphasize science and nutrition, alongside major distributor events such as its Herbalife Honors leadership meeting in Vienna and large-scale training gatherings in India. These initiatives, together with the planned launch of Bioniq’s personalized supplements across 11 European countries in late June, the U.S. in July and additional markets later in 2026, aim to enhance brand positioning, distributor engagement and the company’s ability to scale personalized nutrition offerings across key regions.
The most recent analyst rating on (HLF) stock is a Hold with a $17.00 price target. To see the full list of analyst forecasts on Herbalife stock, see the HLF Stock Forecast page.
Spark’s Take on HLF Stock
According to Spark, TipRanks’ AI Analyst, HLF is a Neutral.
The score is mainly held back by financial structure and profitability risk (persistent negative equity and weakened operating profitability), partially offset by consistently positive cash generation. Technicals are moderately supportive with price above key moving averages and positive momentum, while valuation looks favorable due to the low P/E. The latest earnings call and refinancing-related events add incremental support via improving growth/cash flow trends and reduced interest/refinancing pressure.
To see Spark’s full report on HLF stock, click here.
More about Herbalife
Herbalife Ltd., listed on the NYSE under ticker HLF, operates in the global nutrition and wellness industry, selling dietary supplements, weight-management products and related health offerings primarily through a network of independent distributors. The company focuses on personalized nutrition and is expanding its portfolio and packaging to better align products with specific health and nutrition goals worldwide.
Average Trading Volume: 1,463,921
Technical Sentiment Signal: Buy
Current Market Cap: $1.64B
Learn more about HLF stock on TipRanks’ Stock Analysis page.